These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12814453)

  • 21. The effect of silymarin on oral nifedipine pharmacokinetics.
    Fuhr U; Beckmann-Knopp S; Jetter A; Lück H; Mengs U
    Planta Med; 2007 Nov; 73(14):1429-35. PubMed ID: 17968815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of turmeric extract on the pharmacokinetics of nifedipine after a single oral administration in healthy volunteers.
    Ikehata M; Ohnishi N; Egami S; Kishi H; Shin Y; Takara K; Tsuchishita Y; Tokuda N; Hori S; Yatani Y; Fujimura Y; Kusumoto M; Tatami R; Yoshioka M; Kuroda K; Yamada S; Yokoyama T
    J Diet Suppl; 2008; 5(4):401-10. PubMed ID: 22436099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic interactions of nifedipine and quinidine.
    Hippius M; Henschel L; Sigusch H; Tepper J; Brendel E; Hoffmann A
    Pharmazie; 1995 Sep; 50(9):613-6. PubMed ID: 7480098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of licochalcone A on the bioavailability and pharmacokinetics of nifedipine in rats: possible role of intestinal CYP3A4 and P-gp inhibition by licochalcone A.
    Choi JS; Choi JS; Choi DH
    Biopharm Drug Dispos; 2014 Oct; 35(7):382-90. PubMed ID: 24903704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significant drug-drug interaction between warfarin and nafcillin.
    King CA; Babcock KM; Godios RJ; King BS
    Ther Adv Drug Saf; 2018 Nov; 9(11):667-671. PubMed ID: 30479741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pantoprazole does not interact with nifedipine in man under steady-state conditions.
    Bliesath H; Huber R; Steinijans VW; Koch HJ; Kunz K; Wurst W
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S81-5. PubMed ID: 8793608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacokinetics and pharmacodynamics of nifedipine at steady state during concomitant administration of cimetidine or high dose ranitidine.
    Khan A; Langley SJ; Mullins FG; Dixon JS; Toon S
    Br J Clin Pharmacol; 1991 Oct; 32(4):519-22. PubMed ID: 1958451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient Variables Associated with Nafcillin Plasma Concentrations and Toxicity.
    Benefield RJ; Barker BC; Gast CM; Alexander DP
    Pharmacotherapy; 2016 Sep; 36(9):994-1002. PubMed ID: 27485941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative pharmacokinetics of different oral nifedipine preparations in healthy Brazilian volunteers.
    Vianna-Jorge R; Sudo RT; Melo PA; Suarez-Kurtz G
    Braz J Med Biol Res; 1992; 25(4):385-91. PubMed ID: 1342215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol.
    Swaisland HC; Ranson M; Smith RP; Leadbetter J; Laight A; McKillop D; Wild MJ
    Clin Pharmacokinet; 2005; 44(10):1067-81. PubMed ID: 16176119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined effects of itraconazole and CYP2D6*10 genetic polymorphism on the pharmacokinetics and pharmacodynamics of haloperidol in healthy subjects.
    Park JY; Shon JH; Kim KA; Jung HJ; Shim JC; Yoon YR; Cha IJ; Shin JG
    J Clin Psychopharmacol; 2006 Apr; 26(2):135-42. PubMed ID: 16633141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic interaction between ketoconazole and praziquantel in healthy volunteers.
    Ridtitid W; Ratsamemonthon K; Mahatthanatrakul W; Wongnawa M
    J Clin Pharm Ther; 2007 Dec; 32(6):585-93. PubMed ID: 18021336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of nifedipine derived from a new retard tablet formulation.
    Avgerinos A; Gorrod JW
    Eur J Drug Metab Pharmacokinet; 1990; 15(4):273-8. PubMed ID: 2088764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of bioequivalence of a new fixed-dose combination of nifedipine and candesartan with the corresponding loose combination as well as the drug-drug interaction potential between both drugs under fasting conditions.
    Brendel E; Weimann B; Dietrich H; Froede C; Thomas D
    Int J Clin Pharmacol Ther; 2013 Sep; 51(9):753-62. PubMed ID: 23849325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telithromycin, but not montelukast, increases the plasma concentrations and effects of the cytochrome P450 3A4 and 2C8 substrate repaglinide.
    Kajosaari LI; Niemi M; Backman JT; Neuvonen PJ
    Clin Pharmacol Ther; 2006 Mar; 79(3):231-42. PubMed ID: 16513447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects on metabolic clearance when administering a potent CYP3A autoinducer with the prototypic CYP3A inhibitor, ketoconazole.
    Ayan-Oshodi MA; Willis BA; Annes WF; Lowe SL; Friedrich S; de la Peña A; Zhang W; Brown T; Wise SD; Hall SD
    Drug Metab Dispos; 2012 Oct; 40(10):1945-52. PubMed ID: 22789530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers.
    Cainazzo MM; Pinetti D; Savino G; Bartiromo M; Forgione A; Bertolini A
    Drugs Exp Clin Res; 2005; 31(3):115-21. PubMed ID: 16033250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiologically based pharmacokinetic modeling of CYP3A4 induction by rifampicin in human: influence of time between substrate and inducer administration.
    Baneyx G; Parrott N; Meille C; Iliadis A; Lavé T
    Eur J Pharm Sci; 2014 Jun; 56():1-15. PubMed ID: 24530864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioavailability and pharmacokinetics of nifedipine administered by different routes in healthy volunteers.
    Palma-Aguirre JA; Rosas-Alcázar G; Rodríguez JM; León-Urrea F; Montoya-Cabrera MA
    Arch Invest Med (Mex); 1989; 20(2):129-35. PubMed ID: 2604495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid and simultaneous determination of nifedipine and dehydronifedipine in human plasma by liquid chromatography-tandem mass spectrometry: Application to a clinical herb-drug interaction study.
    Wang XD; Li JL; Lu Y; Chen X; Huang M; Chowbay B; Zhou SF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):534-44. PubMed ID: 17339138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.